Clinical trial
Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study
NCT02994563 is registered in ClinicalTrials.gov with Amnis Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study
- Lead sponsor
- Amnis Therapeutics
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 7, 2019
- Completion date
- March 1, 2021
- Enrollment
- 5 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.